A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
Clinical trial NCT02124148 · COMPLETED
Trial details
- NCT number
- NCT02124148
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-18
- Primary completion
- 2020-02-13
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.